Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001391609-17-000038
Filing Date
2017-02-21
Accepted
2017-02-21 17:05:21
Documents
47
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_nulife123116.htm 10-Q 304443
2 AMENDED AND RESTATED ARTICLES OF INCORPORATION ex3_1amendedarticles.htm EX-3.1 18991
3 AMENDED AND RESTATED BYLAWS ex3_2amendedbylaws.htm EX-3.2 105828
4 SECTION 302 CEO CERTIFICATION ex31_1302certification.htm EX-31.1 12165
5 SECTION 906 CEO CERTIFICATION ex32_1906certification.htm EX-32.1 3943
  Complete submission text file 0001391609-17-000038.txt   1770237

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE nulf-20161231.xml EX-101.INS 255755
7 XBRL SCHEMA FILE nulf-20161231.xsd EX-101.SCH 18741
8 XBRL CALCULATION FILE nulf-20161231_cal.xml EX-101.CAL 26418
9 XBRL DEFINITION FILE nulf-20161231_def.xml EX-101.DEF 35491
10 XBRL LABEL FILE nulf-20161231_lab.xml EX-101.LAB 121496
11 XBRL PRESENTATION FILE nulf-20161231_pre.xml EX-101.PRE 101261
Mailing Address 1031 CALLE RECODO, SUITE B SAN CLEMENTE CA 92673
Business Address 1031 CALLE RECODO, SUITE B SAN CLEMENTE CA 92673 949-973-0684
NuLife Sciences, Inc. (Filer) CIK: 0001592603 (see all company filings)

EIN.: 463876675 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 333-193220 | Film No.: 17625863
SIC: 7310 Services-Advertising